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SUMMARY The inhibitory effect of intravenous secretin and intrajejunal acid infusion on basal and pentagastrin-induced gastric acid secretion as well as the stimulatory influence of both infusions on pancreatic flow rate and bicarbonate output were compared in two groups of healthy subjects.
Secretin strongly inhibited basal acid output and slightly decreased pentagastrin induced gastric secretion.
Intrajejunal acid infusion did not affect the gastric secretion but resulted in an increase in pancreatic volume flow and bicarbonate output reaching about 40 % of the pancreatic response to secretin' infused intravenously in a dose of 2 units per kilogram per hour. It is concluded that this provides evidence that secretin is a strong inhibitor of spontaneous gastric acid secretion and that acid in the jejunum causes the release of secretin in man.
It has been shown already that the acidification of the duodenum in man results in the inhibition of gastric acid secretion (Johnston and Duthie, 1966;  Konturek, 1969) and in the stimulation of the pancreatic flow rate and bicarbonate output (Lagerl6f, Rudewald, and Perman, 1960) due to endogenous release of secretin.
Studies in animals have suggested that the area in which secretin can be released or isolated extends beyond the duodenum to the upper part of the intestines (Wertheimer and Lepage, 1901; Mellanby and Huggett, 1926; Weaver, 1927; Konturek, Dubiel and Gabrys, 1969) . No study, however, has been undertaken to examine the influence of acid introduced into the jejunum on both gastric and pancreatic secretion in man.
The present report describes investigations on The gastric and duodenal juices were aspirated separately by a vacuum pump at a negative pressure of about 30 mm Hg and collected in 15-minute batches. The acidity of the gastric juice was measured by titrating 02 ml samples of gastric juice with 0.1 N NaOH to pH 7.0 using an automatic titrator (Autoburet, Radiometer, Copenhagen) . Acid output was expressed in m-equiv/15 minutes.
The bicarbonate concentration of the duodenal aspirates was estimated in 0.5 ml samples by adding 1-0 ml of 0-1 N HCI, boiling and backtitrating with 0.1 N NaOH to pH 7T0 (Autoburet, Radiometer Effect ofsecretin andjejunal acidification on gastric and pancreatic secretion in man Pancreatic flow rate and bicarbonate output during the jejunal acidification rose to a peak within the first two 15-minute periods of acid instillation into the jejunal loop and then showed a tendency to decline towards the basal level in both groups of subjects. The volume flow and bicarbonate output when acid was infused into the jejunum reached about 40% of the highest level attained with secretin stimulation (Figures  3 and 4) .
Discussion
A number of studies in animals have shown that secretin is capable of inhibiting gastric acid secretion (Greenlee, Longhi, Guerrero, Nelsen, El-Bedri, and Dragstedt, 1957; Wormsley and Grossman, 1964; Johnson and Grossman, 1968; Vagne, Stening, Brooks, and Grossman, 1968; Konturek, 1969) . Recent reports 1969 ) from Grossman's laboratory have demonstrated conclusively, in the dog, that secretin might account for all the inhibition of gastric acid secretion produced by duodenal acidification, and that this hormone is relatively more potent as an inhibitor of gastric secretion than as a stimulator of pancreatic secretion. They suggest that secretin is the only enterogastrone released by acid in the duodenum.
We have already shown, in cats, that gastric acid secretion is much more resistant to the inhibitory action of secretin (Konturek, 1969; Konturek et al, 1969b) and that this hormone cannot be entirely responsible for the inhibition of gastric secretion by acid in the duodenum. It was also demonstrated that secretin can be endogenously released by acid 'in the duodenum as well as in the jejunum (Konturek et al, 1969a) . Although in the latter instance almost maximal pancreatic flow rate was attained no inhibition of gastric secretion was observed.
Previous studies in man (Kamionkowski, Grossman, and Fleshler, 1964; Dinoso, Chey, and Lorber, 1966; Wormsley, 1968a) showed that secretin does not invariably inhibit gastric acid secretion but that duodenal acidification resulted in rapid and strong inhibition of gastric secretion (Johnstone and Duthie, 1966; Konturek, 1969 1969) and suggests that secretin in man, either released by acid in the jejunum or exogenously administered, is stronger as a stimulator of pancreatic secretion than as an inhibitor of gastric acid secretion.
The high cost of secretin precluded the use of larger doses in these trials, which might have displayed a stronger inhibitory action on gastric secretion. The dose used in this study however, has been shown by others (Isenberg and Grossman, 1969; Wormsley, 1968b) to induce almost maximal pancreatic secretion and thus, according to Grossman's criteria (Johnson and Grossman, 1968) may be considered as physiological.
Since side effects like nausea and retching were seen when it was attempted to introduce larger amounts of acid into the jejunum, it is not certain whether the endogenous release of secretin was complete. In addition, the 
